Update on Infantile Haemangioma

Hajheydari, Zohreh; Shahmohammadi, Soheila; Talaee, Rezvan

Volume 2, Issue 1 (2-2014) J. Pediatr. Rev 2014, 2(1): 29-38 | Back to browse issues page

Mendeley

Zotero

RefWorks

Hajheydari Z, Shahmohammadi S, Talaee R. Update on Infantile Haemangioma. J. Pediatr. Rev 2014; 2 (1) :29-38
URL: http://jpr.mazums.ac.ir/article-1-64-en.html

Update on Infantile Haemangioma

Zohreh Hajheydari ^*

¹, Soheila Shahmohammadi²

, Rezvan Talaee³

1- , zhajheidari@mazums.ac.ir
2- Journal of Pediatric Review Office
3- Kashan University of Medical Sciences

Abstract: (8319 Views)

Infantile Haemangiomas (IH) are the most common vascular tumors occurring in early childhood, with a prevalence of approximately 5-10% of infants. These vascular tumors are divided into two main groups including infantile haemangioma and vascular malformations. Although, haemangioma of infancy are common, benign and self-limited tumors, a significant percent of these lesions are associated with substantial morbidity in infancy and childhood. All currently used treatments have significant risks. Dramatic improvement of complicated haemangioma of infancy to propranolol was recently reported. Herein, we review infantile haemangioma as a whole with focus on the therapeutic efficacy of systemic and topical propranolol as a beta-blockers for the management of infantile haemangioma.

Keywords: Beta-Blockers, Propranolol, Infantile haemangiomas

Full-Text [PDF 257 kb] (4120 Downloads)

Type of Study: Narrative Review |
Received: 2013/10/20 | Accepted: 2014/01/7 | Published: 2014/01/7

Send email to the article author

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb